MGMT Promoter Methylation Is Prognostic but Not Predictive...

Journal of Clinical Oncology 2009 / 12 Vol. 27; Iss. 35

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

van den Bent, M. J., Dubbink, H. J., Sanson, M., van der Lee-Haarloo, C. R., Hegi, M., Jeuken, J. W.M., Ibdaih, A., Brandes, A. A., Taphoorn, M. J.B., Frenay, M., Lacombe, D., Gorlia, T., Dinjens, W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2009.24.1034
Date:
December, 2009
File:
PDF, 133 KB
english, 2009
Conversion to is in progress
Conversion to is failed